logo-altasciences

EN - Main navigation

  • Proactive Drug Development
  • Solutions
  • Compare Us
  • Facilities
  • About Us
  • Resource Center
  • Careers
  • News & Events
  • Contact Us
  • Participate in a study
Français
  • Home
  • Clinical Services
  • Current: DRUG-DRUG INTERACTION

DRUG-DRUG INTERACTION

Share this page

Drug-drug and drug-alcohol interaction studies range from simple two-way crossover studies to complex, multi-cohort, adaptive designs. Altasciences has designed, conducted, analyzed, and reported on hundreds of these studies — from the simplest to the most complex.

Our pharmacokineticists review the investigator brochure to determine the studies required, and the ideal inhibitor, inducer, or substrate to use. Our bioanalytical department has validated methods, and we have clinical experience, with almost all common substrates. Our designs are based on literature and in-house experience.

We have conducted single interaction, multiple interactions across cohorts, or multiple interactions within a cohort (cocktail) studies. We routinely perform CYP genotypic to exclude subjects or stratify the groupings.

Consult our general DDI Fact Sheet

PARTICIPANTS

  • Healthy Normal Volunteers
  • Special populations – elderly, CYP, genotypic
  • Patient populations
100s

OF DDI STUDIES
CONDUCTED

RELATED RESEARCH

Related Research

The Altascientist — Understanding the intrinsic and extrinsic factors that alter drug exposure and toxicity

THERAPEUTIC AREAS

Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.

 

Learn More

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

Stay connected

  • linkedin
  • youtube

Footer

    • Solutions

      • Preclinical Services
      • Clinical Services
      • Manufacturing and Analytical Services
      • Bioanalytical Services
      • Research Support Services
      • Development Programs
    • News & Events

      • Altasciences Events
      • Press Releases
      • Altasciences in the News
      • Press Kit
    • Resource Center

      • The Altascientist
      • Webinars/Podcasts
      • Newsletters
      • Scientific Publications
      • Blog
      • Videos
    • Study Types

      • Preclinical
      • Lead Optimization
      • Pharmacology
      • Pharmacokinetics/​Pharmacodynamics
      • Acute Toxicology
      • Dose Range Finding​/​Maximum Tolerated Dose
      • Repeated Dose Toxicity
      • Safety Pharmacology
      • Sub-Chronic/Chronic, Repeated Dose Toxicity
      • Clinical
      • First in Human
      • Proof of Concept
      • Bioavailability/Bioequivalence
      • Pharmacokinetics in Special Populations
      • Human Abuse Potential
      • Driving Simulation
      • Drug-Drug Interaction
      • QT Assessment
      • Renal and Hepatic Impaired
      • Imaging
      • Biologics​/​Biosimilars
    • Therapeutic Areas

      • Cardiology
      • Dermatology
      • Gastroenterology
      • Hematology
      • Immunology
      • Infectious Diseases
      • Metabolism and Endocrinology
      • Neurology
      • Oncology
      • Ophthalmology
      • Orthopedics
      • Psychiatry
      • Respirology
      • Rheumatology
      • Substance Abuse
      • Urology
      • Women’s Health
    • About us

      • History
      • Our Origins
      • Awards
      • Testimonials
    • Careers

    • Contact Us

    • Locations

    • Stay connected

      • Facebook
      • Youtube

2025 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy

Have a question?

I'd be happy to help.

Captcha is required.